1,233 results on '"Constine, Louis S"'
Search Results
152. Involved Field Radiation After Autologous Stem Cell Transplant for Diffuse Large B-Cell Lymphoma in the Rituximab Era
153. Radiation-Related Heart Disease: Current Knowledge and Future Prospects
154. Improving Normal Tissue Complication Probability Models: The Need to Adopt a “Data-Pooling” Culture
155. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues
156. The Lessons of QUANTEC: Recommendations for Reporting and Gathering Data on Dose–Volume Dependencies of Treatment Outcome
157. Radiation Dose–Volume Effects in the Heart
158. Use of Normal Tissue Complication Probability Models in the Clinic
159. Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors
160. The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity
161. Extranodal Presentation in Limited Stage DLBCL As a Prognostic Marker in Three Sequential SWOG Trials S0014, S0313 and S1001 (NCT00005089, NCT00070018, NCT01359592)
162. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group
163. Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group
164. Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review
165. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
166. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study
167. Radiation-Associated Coronary Disease in Young Cancer Survivors
168. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425
169. Second Primary Head and Neck Cancer After Hodgkin Lymphoma: A Population-Based Study of 44,879 Survivors of Hodgkin Lymphoma
170. Patterns and Timing of Initial Relapse in Patients Subsequently Undergoing Transplantation for Hodgkin's Lymphoma
171. The Differential Protection by WR2721 of Skin versus Growing Cartilage Following Irradiation in Weanling Rats
172. Cranial Irradiation as an Additional Risk Factor for Anthracycline Cardiotoxicity in Childhood Cancer Survivors: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study
173. Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study
174. Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma
175. Hematopoietic System
176. Thyroid
177. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors : A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
178. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors : evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
179. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
180. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group
181. Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
182. Spurious progression in pediatric brain tumors
183. Incidental brain lesions in children: to treat or not to treat?
184. ACR Appropriateness Criteria ® on Hodgkin's Lymphoma—Favorable Prognosis Stage I and II
185. Malignant peripheral nerve sheath tumors (MPNST): A SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population
186. Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: A population-based study of 28,844 patients
187. ACR Appropriateness Criteria® Pediatric Hodgkin Lymphoma
188. A systematic review of dental late effects in survivors of childhood cancer
189. Problem-solving skills training in adult cancer survivors: Bright IDEAS-AC.
190. Impact of using volumetric dosimetry to screen childhood cancer survivors for radiation-related late effects.
191. Low-dose radiation to cardiac substructures and late-onset cardiac disease: A report from the Childhood Cancer Survivor Study (CCSS).
192. Feasibility of fully remote administration of problem-solving skills training (PSST) to adult cancer survivors in community settings.
193. Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A Pediatric Normal Tissue Effects in the Clinic (PENTEC) Comprehensive Review
194. Late effects of radiation therapy in pediatric patients and survivorship
195. Pediatric classical Hodgkin lymphoma
196. Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Assess Normal Tissue Radiation Dose-Volume-Response Relationships for Children With Cancer
197. Primary Hypothyroidism in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review
198. Late effects of therapy for Hodgkin’s lymphoma
199. Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
200. Prologue: Surviving Cancer: SEER Statistics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.